IDH1 and glioblastoma: In another study, the knockdown of wild‐type IDH in GBM cell lines and in GBM xenograft models also reduced NADPH levels and NADPH‐dependent metabolites such as deoxynucleotides and glutathione, correlating with an improvement in the therapeutic response to radiotherapy [76].